Because of its risks, ERCP is considered to be a primarily therapeutic procedure which is indicated when other noninvasive tests have identified biliopancreatic pathologies or, as in this case, choledocholithiasis.
Dentro de los primeros se encuentran la CPRE y la CIO y entre los segundos la ecografía hepatobiliar, colangiografía por resonancia magnética y la ecoendoscopia.